Zakrzewski Joseph S 4
4 · AN2 Therapeutics, Inc. · Filed Dec 23, 2024
Insider Transaction Report
Form 4
Zakrzewski Joseph S
Director
Transactions
- Award
Common Stock
2024-12-19+9,816→ 135,015 total
Holdings
- 405,880(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.
- [F2]These shares are held by Z3 Trust, for which the Reporting Person is a trustee.